Apr 21 |
11 Best Low Price Pharma Stocks To Invest In
|
Apr 19 |
Zacks Industry Outlook Highlights Teva, Dr. Reddy's and Viatris
|
Apr 18 |
3 Generic Drug Stocks to Watch Amid Challenging Market Prospects
|
Apr 18 |
Bill Miller’s Latest 13 Stock Picks
|
Apr 16 |
Viatris to Report First Quarter 2024 Financial Results on May 9, 2024
|
Apr 15 |
Viatris Appoints Corinne Le Goff as Chief Commercial Officer
|
Apr 15 |
Viatris Announces Launch of First Bioequivalent Generic Version of Copaxone® 20 mg/mL Once-Daily in Canada
|
Apr 8 |
Viatris Stock: Way Too Undervalued With $1 Billion Buyback Potential
|
Apr 4 |
Viatris- Theramex deal for women's care products raises antitrust concerns in U.K.
|
Apr 4 |
Competition watchdog says HRT drug deal could raise prices
|